TransMedics EBITDA 2019-2024 | TMDX
- TransMedics 2023 EBITDA was -0.021B, a 26.5% decline from 2022.
- TransMedics 2022 EBITDA was -0.028B, a 25.66% decline from 2021.
- TransMedics 2021 EBITDA was -0.038B, a 51.61% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.